NEW YORK, Nov. 9 (GenomeWeb News) - Shares in CombiMatrix were up 12.68 percent at $3.20 in heavy tradining late this afternoon, adding fuel to an up-tick in stock price since the company released string third-quarter revenues three weeks ago.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.
The New York Times reports on the shifting interpretations of what some genetic variants mean over time.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.